Financial News
Latest News about Can/Fite BioPharma Ltd/
Recent news which mentions Can/Fite BioPharma Ltd/
Multiple Shots On Goal: Can-Fite's Late-Stage Clinical Pipeline Hits Positive Results
December 13, 2022
Tickers
CANF
From Benzinga
This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers
October 27, 2022
From Benzinga
Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?
April 12, 2022
From Benzinga
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
March 24, 2022
From Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
February 03, 2022
From Benzinga
A New Oral Therapy for Psoriasis Could Be Coming Soon
January 24, 2022
From Benzinga
PRIOR TO PHASE III PSORIASIS DATA RELEASE CAN FITE REPORTS THAT PICLIDENOSON DESTROYS PATHOLOGICAL SKIN CELLS IN VITRO
January 13, 2022
Tickers
CANF
From Benzinga
From Benzinga
Dawson James - Can-Fite (CANF) Buy Rated - Expected Milestones
January 05, 2022
Tickers
CANF
From Benzinga
Positive Data from Phase IIa Can-Fite NASH Study Published in Leading Peer Reviewed Scientific Journal
October 21, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
